11.01.2021 • News

Moderna Appoints Chief Commercial Officer

As it rolls out an increasing number of doses of its mRNA-based Covid-19 vaccine, US biotech Moderna has appointed a pharma industry veteran to spearhead the effort. Corinne Le Goff will take up the position on Jan. 19.

Le Goff’s last role was senior vice president of Amgen and president of its US business. The pharmacist by training is credited with overseeing Amgen’s Otezla integration after the company acquired the drug from Celgene in 2019, along with boosting sales of cholesterol med Repatha and migraine launch Aimovig.

“Corinne is joining us at an important time as we launch our Covid-19 vaccine, prepare to start the Phase 3 study of our CMV vaccine and pivot to a commercial-stage company,” Moderna CEO Stéphane Bancel said in a statement.

Author: Dede Williams, Freelance Journalist

As it rolls out an increasing number of doses of its mRNA-based Covid-19... — As it rolls out an increasing number of doses of its mRNA-based Covid-19 vaccine, US biotech Moderna has appointed a pharma industry veteran to spearhead the effort. Corinne Le Goff will take up the position on Jan. 19. (c) JULIE BOURGES

From Lab to Market Challenge

Choose your favourite among the finalists

Vote Now: Germany's Most Promising Chemistry Start-ups

The "From Lab to Market Challenge" brings together the most promising founders from chemistry, materials science, and industrial biotechnology. Starting June 1st, you can cast your public vote for the finalists on CHEManager.com — before the award ceremony with €10,000 in prizes takes place on June 25th.

Interview

Trade and Competitiveness

The UK Chemical Supply Chain

The CBA, led by CEO Tim Doggett, is steering the UK chemical supply chain through trade uncertainty, sustainability pressures and logistics challenges, as he explains in this interview with CHEManager.